Sale!

ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 Genetic Test

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The “ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 Genetic Test” is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the ADAM17 gene, which are implicated in causing a rare, severe condition known as inflammatory skin and bowel disease neonatal type 1 (ISBDN1). This condition manifests shortly after birth, characterized by significant inflammation affecting the skin and gastrointestinal tract, leading to a range of severe symptoms and complications.

The ADAM17 gene plays a crucial role in the regulation of inflammation and the maintenance of skin and mucosal barrier integrity. Mutations in this gene disrupt these processes, leading to the symptoms observed in affected individuals. Early and accurate diagnosis through genetic testing is vital for managing the condition, as it allows for tailored treatment strategies aimed at mitigating symptoms and improving quality of life.

The test is priced at 3200 AED and is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. By leveraging advanced genomic technologies, DNA Labs UAE provides precise and reliable results, aiding in the effective diagnosis and management of rare genetic conditions such as ISBDN1. This test is essential for families with a history of the condition or those exhibiting symptoms, offering them crucial insights into their genetic health and guiding clinical decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 Genetic Test

Are you or a loved one experiencing symptoms of inflammatory skin and bowel disease neonatal type 1? DNA Labs UAE offers a comprehensive genetic test for the ADAM17 gene, which plays a crucial role in inflammation and immune response.

Test Details

The ADAM17 gene, also known as ADAM metallopeptidase domain 17, codes for a protein called ADAM17 or tumor necrosis factor-alpha converting enzyme (TACE). This protein is responsible for shedding various cell surface proteins, including cytokines, growth factors, and receptors.

Inflammatory skin and bowel disease neonatal type 1 is a rare genetic disorder caused by mutations in the ADAM17 gene. This condition is characterized by severe inflammation of the skin and gastrointestinal tract, leading to symptoms such as skin rashes, diarrhea, and failure to thrive.

Our genetic test utilizes Next-Generation Sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes, including the ADAM17 gene. NGS technology enables rapid and cost-effective sequencing of a large number of genes, providing a comprehensive assessment of genetic variants associated with inflammatory skin and bowel disease neonatal type 1.

Test Components and Price

  • Test Name: ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 Genetic Test
  • Components: NGS Technology
  • Price: 3200.0 AED
  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks
  • Test Type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 Genetic Test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1.

Benefits of Genetic Testing

NGS genetic testing for ADAM17 gene mutations can help in the diagnosis of inflammatory skin and bowel disease neonatal type 1. Identifying the specific genetic mutation can aid in confirming the diagnosis, predicting disease severity, and guiding treatment decisions. It can also be used for genetic counseling and family planning purposes.

It is crucial to note that genetic testing should always be done in consultation with a healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name ADAM17 Gene Inflammatory skin and bowel disease neonatal type 1 Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ADAM17 Gene Inflammatory skin and bowel disease, neonatal, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ADAM17 Gene Inflammatory skin and bowel disease, neonatal, type 1 NGS Genetic DNA Test gene ADAM17
Test Details

ADAM17 gene, also known as ADAM metallopeptidase domain 17, is a gene that codes for a protein called ADAM17, or tumor necrosis factor-alpha converting enzyme (TACE). This protein is involved in the shedding of various cell surface proteins, including cytokines, growth factors, and receptors. ADAM17 plays a crucial role in inflammation and immune response.

Inflammatory skin and bowel disease, neonatal, type 1 is a rare genetic disorder that is caused by mutations in the ADAM17 gene. This condition is characterized by severe inflammation of the skin and the gastrointestinal tract, leading to symptoms such as skin rashes, diarrhea, and failure to thrive.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the ADAM17 gene. NGS technology enables the rapid and cost-effective sequencing of a large number of genes, providing a comprehensive assessment of genetic variants that may be associated with a particular condition.

NGS genetic testing for ADAM17 gene mutations can help in the diagnosis of inflammatory skin and bowel disease, neonatal, type 1. Identifying the specific genetic mutation can aid in confirming the diagnosis, predicting disease severity, and guiding treatment decisions. It can also be used for genetic counseling and family planning purposes.

It is important to note that genetic testing should always be done in consultation with a healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.